Pylclari 1 000 MBq/ml solution for injection

ATC: V09IX16, SÚKL code  0268420,  

 Pylclari 1 500 MBq/ml solution for injection

ATC: V09IX16, SÚKL code 0268421

Therapeutic indication

This product is for diagnostic use only.

Pylclari is indicated for the detection of prostate-specific membrane antigen (PSMA)-positive lesions by positron emission tomography (PET) in adults with prostate cancer (PCa) in the following clinical settings:

• Primary staging of patients with high-risk PCa prior to initial curative therapy,

• To localize PCa recurrence in patients with suspected recurrence based on rising serum prostate-specific antigen (PSA) levels after primary treatment with curative intent.

Order by: Wednesday

Delivery: Tuesday of the following week (2x per month)

*Note: Distribution in accordance with Act No. 378/2007 Coll., on medicinal products, as amended

SPC and PIL – see SÚKL website: https://prehledy.sukl.cz/prehled_leciv.html#/leciva/0268420